Lv4
570 积分 2026-09-17 加入
Volumetric stone size assessment did not demonstrate improved prediction of treatment success compared with cumulative stone diameter
1天前
已完结
Circulating Tumor Cell Synaptophysin and Androgen Receptor Expression Reflect Prostate Cancer Phenotypes in Metastatic Disease
2天前
已完结
Talazoparib plus enzalutamide versus placebo plus enzalutamide in metastatic androgen pathway modulator-resistant (castration-resistant) prostate cancer (TALAPRO-2): a biomarker analysis of circulating tumour DNA and cells for prognosis and molecular profiling
4天前
已完结
ENZARAD (ANZUP 1303): Phase 3 Trial of Enzalutamide With Androgen Deprivation Therapy and Radiation Therapy in High-Risk Localized or Locally Advanced Prostate Cancer
7天前
已完结
Blocking Minor Intron Splicing Disrupts DNA Repair and Overcomes Therapy Resistance in Prostate and Breast Cancer
10天前
已完结
The effect of ureteral stenting on the risk of metachronous upper tract urothelial carcinoma in patients with bladder tumors involving the ureteral orifice
15天前
已关闭
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
21天前
已完结
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
21天前
已完结
Oncological Outcomes of Neoadjuvant Chemotherapy in High-Risk UTUC: A Multicenter Study
21天前
已完结
皖公网安备34019202002308
